Tag : immuno-oncology

Healthcare Infrastructure, Operations & Supply Chain

Agenus Closes $141M Collaboration with Zydus Lifesciences

Business Wire
by Business Wire037
Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced the closing of its previously disclosed strategic collaboration with Zydus Lifesciences Ltd. The agreement...
Clinical Research, Pharma & Healthcare Financing

Mondego Bio Selects PTPN2 Inhibitor, Targets First Trials in 2026

PR Newswire
by PR Newswire031
Mondego Bio, a clinical-stage biotechnology company developing next-generation small-molecule immuno-oncology therapies, today announced the formal selection of its lead clinical candidate, ZE00-0388, a highly selective...